Innoviva, Inc. INVA
NASDAQ · United States · Health Technology
$20.55-0.66 (-3.11%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -1.14 | 0.44 | -361.5% | $119.59M | +7.8% | +1.2%$20.86→$21.11 |
| Q1 2026 | 2026-05-06 | 0.44 | 0.43 | +2.3% | — | — | +0.7%$22.65→$22.80 |
| Q4 2025 | 2026-02-25 | 1.94 | 0.34 | +470.6% | — | — | +0.5%$23.42→$23.54 |
| Q3 2025 | 2025-11-05 | 1.08 | 0.46 | +134.8% | — | — | +13.4%$18.15→$20.58 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.